Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2015 1
2016 1
2017 2
2018 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
P2X7 antagonists for CNS indications: recent patent disclosures.
Pevarello P, Bovolenta S, Tarroni P, Za L, Severi E, Torino D, Vitalone R. Pevarello P, et al. Among authors: bovolenta s. Pharm Pat Anal. 2017 Mar;6(2):61-76. doi: 10.4155/ppa-2016-0044. Epub 2017 Mar 1. Pharm Pat Anal. 2017. PMID: 28248151 Review.
Publisher Correction: Novel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach.
Beccari AR, Gemei M, Lo Monte M, Menegatti N, Fanton M, Pedretti A, Bovolenta S, Nucci C, Molteni A, Rossignoli A, Brandolini L, Taddei A, Za L, Liberati C, Vistoli G. Beccari AR, et al. Among authors: bovolenta s. Sci Rep. 2018 Mar 6;8(1):4250. doi: 10.1038/s41598-018-21902-z. Sci Rep. 2018. PMID: 29511237 Free PMC article.
Novel selective, potent naphthyl TRPM8 antagonists identified through a combined ligand- and structure-based virtual screening approach.
Beccari AR, Gemei M, Lo Monte M, Menegatti N, Fanton M, Pedretti A, Bovolenta S, Nucci C, Molteni A, Rossignoli A, Brandolini L, Taddei A, Za L, Liberati C, Vistoli G. Beccari AR, et al. Among authors: bovolenta s. Sci Rep. 2017 Sep 8;7(1):10999. doi: 10.1038/s41598-017-11194-0. Sci Rep. 2017. PMID: 28887460 Free PMC article.
DFL23448, A Novel Transient Receptor Potential Melastin 8-Selective Ion Channel Antagonist, Modifies Bladder Function and Reduces Bladder Overactivity in Awake Rats.
Mistretta FA, Russo A, Castiglione F, Bettiga A, Colciago G, Montorsi F, Brandolini L, Aramini A, Bianchini G, Allegretti M, Bovolenta S, Russo R, Benigni F, Hedlund P. Mistretta FA, et al. Among authors: bovolenta s. J Pharmacol Exp Ther. 2016 Jan;356(1):200-11. doi: 10.1124/jpet.115.228684. Epub 2015 Nov 6. J Pharmacol Exp Ther. 2016. PMID: 26546575
Binding Mode Exploration of B1 Receptor Antagonists' by the Use of Molecular Dynamics and Docking Simulation-How Different Target Engagement Can Determine Different Biological Effects.
Gemei M, Talarico C, Brandolini L, Manelfi C, Za L, Bovolenta S, Liberati C, Vecchio LD, Russo R, Cerchia C, Allegretti M, Beccari AR. Gemei M, et al. Among authors: bovolenta s. Int J Mol Sci. 2020 Oct 16;21(20):7677. doi: 10.3390/ijms21207677. Int J Mol Sci. 2020. PMID: 33081372 Free PMC article.
Development of a Ca(2+)-activated photoprotein, Photina, and its application to high-throughput screening.
Bovolenta S, Foti M, Lohmer S, Corazza S. Bovolenta S, et al. J Biomol Screen. 2007 Aug;12(5):694-704. doi: 10.1177/1087057107301497. Epub 2007 May 21. J Biomol Screen. 2007. PMID: 17517900
From c-Photina mouse embryonic stem cells to high-throughput screening of differentiated neural cells via an intermediate step enriched in neural precursor cells.
Cainarca S, Fenu S, Bovolenta S, Arioli P, Menegon A, Lohmer S, Corazza S. Cainarca S, et al. Among authors: bovolenta s. J Biomol Screen. 2010 Oct;15(9):1132-43. doi: 10.1177/1087057110379267. Epub 2010 Sep 10. J Biomol Screen. 2010. PMID: 20834010
Feedback